Related Experiment Video
Updated: Aug 23, 2025
07:07
Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
Published on: January 7, 2019
6.2K
Integrated Bioinformatics Analysis Reveals Novel miRNA as Biomarkers Associated with Preeclampsia
Mariarita Brancaccio1, Caterina Giachino2, Assunta Maria Iazzetta2
1Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Genes
|October 27, 2022
Summary
This study identifies key microRNAs (miRNAs) in preeclampsia, finding nine upregulated miRNAs in plasma. These novel biomarkers could lead to personalized treatments for preeclampsia.
Area of Science:
- Genomics
- Biomarkers
- Reproductive Medicine
Background:
- Preeclampsia is a major cause of maternal and fetal mortality.
- Identifying specific biomarkers is crucial for early detection and management.
Purpose of the Study:
- To identify key microRNAs (miRNAs) associated with preeclampsia.
- To explore the potential functions and therapeutic applications of these miRNAs.
Main Methods:
- Downloaded and analyzed miRNA expression profiles (GSE119799 for plasma, GSE177049 for placenta).
- Compared miRNA expression between preeclampsia patients and controls using counts per million (CPM).
- Performed differential expression analysis (|logFC| ≥ 1, FDR ≤ 0.05) to identify significant miRNAs.
Main Results:
- Identified 358 common miRNAs between plasma and placenta datasets.
- Highlighted 321 common miRNAs between plasma and placenta with differential expression analysis.
- Discovered nine upregulated miRNAs in plasma, including four common and five unique to plasma.
Conclusions:
- The identified nine miRNAs show potential as non-invasive biomarkers for preeclampsia.
- These miRNAs may serve as therapeutic targets for developing personalized preeclampsia treatments.
